CORT

#3684
Corcept Therapeutics Incorporated - Common Stock
0.6 9 USD
-98.98%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
0.69
0.69
Rango anual
0.69
89.00
Cambio diario
-98.98%
Variación mensual
-98.52%
Variación en los últimos 6 meses
-99.11%
Cambio anual
-99.05%
Cierres anteriores
68.3 8
Open
0.6 9
Mínimo
0.6 9
High
0.6 9
Volumen
220
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 74.6 M
  • Employee 730
  • Founded 1998
  • CEO N/A
  • Website www.corcept.com
  • Headquarter Delaware, United States
  • FIGI BBG000BKJG33
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
42.44
Relación precio/flujo de caja
5.48

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

Noticias